BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$2.42B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.87B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$704M |
| 4 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$517M |
| 5 |
Nike
NKE
|
+$489M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$301M |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$283M |
| 3 |
State Street SPDR S&P Retail ETF
XRT
|
+$156M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$72M |
| 5 |
NVIDIA
NVDA
|
+$68.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.16% |
| 2 | Consumer Discretionary | 6.92% |
| 3 | Financials | 5.71% |
| 4 | Healthcare | 5.18% |
| 5 | Communication Services | 3.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Pediatrix Medical
MD
$2.16B
| $1.25M | ﹤0.01% |
53,231
-15,899
| -23% | -$389K |
|
|
PMT
2002
PennyMac Mortgage Investment
PMT
$824M
| $1.25M | ﹤0.01% |
73,986
-73,749
| -50% | -$1.24M |
|
2003
Genworth Financial
GNW
$3.84B
| $1.25M | ﹤0.01% |
329,761
-153,504
| -32% | -$616K |
|
2004
OFG Bancorp
OFG
$2.28B
| $1.25M | ﹤0.01% |
46,754
-5,935
| -11% | -$165K |
|
2005
Sturm, Ruger & Co
RGR
$602M
| $1.25M | ﹤0.01% |
17,887
-19,901
| -53% | -$1.37M |
|
2006
CALL
Freeport-McMoran
FCX
$93.1B
| $1.24M | ﹤0.01% |
250
-493
| -66% | -$21.8K |
|
|
RCM
2007
DELISTED
R1 RCM Inc. Common Stock
RCM
| $1.24M | ﹤0.01% |
46,324
-20,888
| -31% | -$512K |
|
2008
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.62B
| $1.24M | ﹤0.01% |
28,185
-12,357
| -30% | -$547K |
|
2009
PUT
US Bancorp
USB
$102B
| $1.24M | ﹤0.01% |
233
-330
| -59% | -$19K |
|
2010
BlackLine
BL
$1.77B
| $1.24M | ﹤0.01% |
16,913
+3,898
| +30% | +$315K |
|
2011
Radiant Logistics
RLGT
$408M
| $1.23M | ﹤0.01% |
193,542
-9,983
| -5% | -$66.1K |
|
|
ITCI
2012
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.23M | ﹤0.01% |
20,133
+5,189
| +35% | +$269K |
|
2013
Axsome Therapeutics
AXSM
$11.2B
| $1.23M | ﹤0.01% |
29,756
-42,496
| -59% | -$1.32M |
|
2014
PUT
Kimberly-Clark
KMB
$36.7B
| $1.23M | ﹤0.01% |
100
-150
| -60% | -$19.8K |
|
2015
Virtu Financial
VIRT
$5.3B
| $1.23M | ﹤0.01% |
32,969
+8,756
| +36% | +$289K |
|
|
B
2016
CALL
Barrick Mining
B
$68.5B
| $1.23M | ﹤0.01% |
+500
| New | +$10.8K |
|
2017
Ternium
TX
$10.6B
| $1.22M | ﹤0.01% |
26,771
+19,387
| +263% | +$825K |
|
2018
Simmons First National
SFNC
$3.48B
| $1.22M | ﹤0.01% |
46,555
-32,567
| -41% | -$940K |
|
2019
PUT
Pinduoduo
PDD
$121B
| $1.22M | ﹤0.01% |
304
-482
| -61% | -$24.8K |
|
|
BERY
2020
DELISTED
Berry Global Group, Inc.
BERY
| $1.22M | ﹤0.01% |
22,907
+585
| +3% | +$34.2K |
|
2021
Stewart Information Services
STC
$2.08B
| $1.22M | ﹤0.01% |
20,099
-11,596
| -37% | -$806K |
|
2022
Twist Bioscience
TWST
$7.44B
| $1.21M | ﹤0.01% |
24,602
+6,905
| +39% | +$383K |
|
2023
SITE Centers
SITC
$155M
| $1.21M | ﹤0.01% |
93,090
-85,077
| -48% | -$1.04M |
|
|
LGF.B
2024
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $1.21M | ﹤0.01% |
80,607
+28,857
| +56% | +$418K |
|
2025
Axos Financial
AX
$5.8B
| $1.21M | ﹤0.01% |
26,042
-10,925
| -30% | -$577K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2022 Portfolio in Review
As of Q1 2022, BNP Paribas Financial Markets held 4,480 positions worth $74.4B, up 5.9% from $70.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BNP Paribas Financial Markets deployed $8.44B of net new capital in Q1 2022, opening 238 new positions and adding to 1,135 existing holdings. Its largest new stake was Invesco Emerging Markets Sovereign Debt ETF: 1,028,214 shares worth $23.2M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street Health Care Select Sector SPDR ETF, an estimated $283M trimmed.
- BNP Paribas Financial Markets's largest Q1 2022 buy was Invesco Emerging Markets Sovereign Debt ETF: 1,028,214 shares worth $23.2M.
- BNP Paribas Financial Markets added most to Invesco QQQ Trust in Q1 2022, an estimated $2.42B increase.
- BNP Paribas Financial Markets's biggest Q1 2022 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $283M.
- BNP Paribas Financial Markets fully exited Xilinx Inc in Q1 2022, selling an estimated $301M.
- BNP Paribas Financial Markets's ten largest holdings make up 19% of its $74.4B portfolio in Q1 2022.
- BNP Paribas Financial Markets opened 238 new positions and closed 335 in Q1 2022.
- BNP Paribas Financial Markets's portfolio value rose 5.9% quarter-over-quarter to $74.4B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2022, filed 17 May 2022.